WallStreetZenWallStreetZen

NASDAQ: FEMY
Femasys Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for FEMY

Based on 2 analysts offering 12 month price targets for Femasys Inc

Min Forecast
$6.00+1,590.14%
Avg Forecast
$7.00+1,871.83%
Max Forecast
$8.00+2,153.52%

Should I buy or sell FEMY stock?

Based on 2 analysts offering ratings for Femasys Inc.

Strong Buy
Strong Buy
1 analysts 50%
Buy
1 analysts 50%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their FEMY stock forecasts and price targets.

FEMY stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-08-11
lockedlocked$00.00+00.00%2025-05-13

1 of 1

Forecast return on equity

Is FEMY forecast to generate an efficient return?

Company
-395.63%
Industry
10.18%
Market
-51.7%
FEMY's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is FEMY forecast to generate an efficient return on assets?

Company
-59.49%
Industry
6.17%
FEMY is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

FEMY earnings per share forecast

What is FEMY's earnings per share in the next 3 years based on estimates from 2 analysts?

Avg 1 year Forecast
-$0.54
Avg 2 year Forecast
-$0.53
Avg 3 year Forecast
-$0.41

FEMY revenue forecast

What is FEMY's revenue in the next 3 years based on estimates from 2 analysts?

Avg 1 year Forecast
$6.0M+253.1%
Avg 2 year Forecast
$9.2M+441.42%
Avg 3 year Forecast
$32.8M+1,830.28%
FEMY's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

FEMY revenue growth forecast

How is FEMY forecast to perform vs Medical Instruments & Supplies companies and vs the US market?

Company
157.73%
Industry
8.54%
Market
10.65%
FEMY's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
FEMY's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

FEMY vs Medical Stocks

TickerPricePrice TargetUp/downsideConsensus
FEMY$0.36$7.00+1,871.83%Strong Buy
EKSO$3.75$34.75+826.67%Strong Buy
POAI$0.88N/AN/A
LUCY$1.93N/AN/A
MHUA$0.42N/AN/A
View Top Medical Stocks

Femasys Stock Forecast FAQ

Is Femasys Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 2 Wall Street analysts covering (NASDAQ: FEMY) stock is to Strong Buy FEMY stock.

Out of 2 analysts, 1 (50%) are recommending FEMY as a Strong Buy, 1 (50%) are recommending FEMY as a Buy, 0 (0%) are recommending FEMY as a Hold, 0 (0%) are recommending FEMY as a Sell, and 0 (0%) are recommending FEMY as a Strong Sell.

If you're new to stock investing, here's how to buy Femasys stock.

What is FEMY's earnings growth forecast for 2025-2027?

(NASDAQ: FEMY) Femasys's forecast annual earnings growth rate of N/A is not forecast to beat the US Medical Instruments & Supplies industry's average forecast earnings growth rate of 16.41%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 14.89%.

Femasys's earnings in 2025 is -$21,113,957.On average, 2 Wall Street analysts forecast FEMY's earnings for 2025 to be -$14,573,338, with the lowest FEMY earnings forecast at -$16,071,532, and the highest FEMY earnings forecast at -$13,075,145. On average, 1 Wall Street analyst forecast FEMY's earnings for 2026 to be -$14,437,139, with the lowest FEMY earnings forecast at -$14,437,139, and the highest FEMY earnings forecast at -$14,437,139.

In 2027, FEMY is forecast to generate -$11,168,353 in earnings, with the lowest earnings forecast at -$11,168,353 and the highest earnings forecast at -$11,168,353.

What is FEMY's revenue growth forecast for 2025-2027?

(NASDAQ: FEMY) Femasys's forecast annual revenue growth rate of 157.73% is forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 8.54%, and it is also forecast to beat the US market's average forecast revenue growth rate of 10.65%.

Femasys's revenue in 2025 is $1,699,232.On average, 2 Wall Street analysts forecast FEMY's revenue for 2025 to be $163,439,310, with the lowest FEMY revenue forecast at $98,063,586, and the highest FEMY revenue forecast at $228,815,034. On average, 1 Wall Street analysts forecast FEMY's revenue for 2026 to be $250,606,942, with the lowest FEMY revenue forecast at $250,606,942, and the highest FEMY revenue forecast at $250,606,942.

In 2027, FEMY is forecast to generate $893,468,228 in revenue, with the lowest revenue forecast at $893,468,228 and the highest revenue forecast at $893,468,228.

What is FEMY's forecast return on assets (ROA) for 2025-2028?

(NASDAQ: FEMY) forecast ROA is -59.49%, which is lower than the forecast US Medical Instruments & Supplies industry average of 6.17%.

What is FEMY's Price Target?

According to 2 Wall Street analysts that have issued a 1 year FEMY price target, the average FEMY price target is $7.00, with the highest FEMY stock price forecast at $8.00 and the lowest FEMY stock price forecast at $6.00.

On average, Wall Street analysts predict that Femasys's share price could reach $7.00 by Aug 11, 2026. The average Femasys stock price prediction forecasts a potential upside of 1,871.83% from the current FEMY share price of $0.36.

What is FEMY's Earnings Per Share (EPS) forecast for 2025-2027?

(NASDAQ: FEMY) Femasys's current Earnings Per Share (EPS) is -$0.91. On average, analysts forecast that FEMY's EPS will be -$0.54 for 2025, with the lowest EPS forecast at -$0.59, and the highest EPS forecast at -$0.48. On average, analysts forecast that FEMY's EPS will be -$0.53 for 2026, with the lowest EPS forecast at -$0.53, and the highest EPS forecast at -$0.53. In 2027, FEMY's EPS is forecast to hit -$0.41 (min: -$0.41, max: -$0.41).

What is FEMY's forecast return on equity (ROE) for 2025-2028?

(NASDAQ: FEMY) forecast ROE is -395.63%, which is considered weak.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.